Literature DB >> 6889932

Reduced nocturnal melatonin secretion in chronic schizophrenia: relationship to body weight.

I N Ferrier, J Arendt, E C Johnstone, T J Crow.   

Abstract

Melatonin was estimated by RIA in samples taken at 24.00 h and 08.00 h from twenty-one male chronic schizophrenics and twelve age--sex matched controls and subsequently in more frequent nocturnal samples from nine of the chronic schizophrenics. The 24.00 h melatonin level and the 24.00/08.00 h melatonin ratio were significantly reduced in the chronic schizophrenic patients. Similar results, with no evidence of subsidiary peaks of melatonin secretion, were obtained in those patients who were retested. No relationships between melatonin secretion and age or anterior pituitary hormone secretion were demonstrated, but an effect of body weight was noted which accounted, in part, for the difference between schizophrenics and controls. These results suggest that the low levels of melatonin noted in studies on depressed patients may not be specific and that body weight must be controlled in subsequent studies of melatonin secretion in patients with psychiatric disease.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6889932     DOI: 10.1111/j.1365-2265.1982.tb01577.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  12 in total

1.  Age, alcoholism and depression are associated with low levels of urinary melatonin.

Authors:  L Wetterberg; B Aperia; D A Gorelick; H E Gwirtzman; M T McGuire; E A Serafetinides; A Yuwiler
Journal:  J Psychiatry Neurosci       Date:  1992-11       Impact factor: 6.186

2.  Melatonin modulates apomorphine-induced rotational behaviour.

Authors:  S Burton; S Daya; B Potgieter
Journal:  Experientia       Date:  1991-05-15

Review 3.  Influence of sleep-wake and circadian rhythm disturbances in psychiatric disorders.

Authors:  D B Boivin
Journal:  J Psychiatry Neurosci       Date:  2000-11       Impact factor: 6.186

4.  Does bright light suppress nocturnal melatonin secretion more in women than men?

Authors:  P Monteleone; G Esposito; A La Rocca; M Maj
Journal:  J Neural Transm Gen Sect       Date:  1995

5.  Melatonin/cortisol ratio in psychiatric illness.

Authors:  I N Ferrier; E C Johnstone; T J Crow; J Arendt
Journal:  Lancet       Date:  1982-05-08       Impact factor: 79.321

6.  Quetiapine reduces nocturnal urinary cortisol excretion in healthy subjects.

Authors:  Stefan Cohrs; Kathrin Pohlmann; Zhenghua Guan; Wolfgang Jordan; Andreas Meier; Gerald Huether; Eckart Rüther; Andrea Rodenbeck
Journal:  Psychopharmacology (Berl)       Date:  2004-01-20       Impact factor: 4.530

Review 7.  Clinical aspects of the melatonin action: impact of development, aging, and puberty, involvement of melatonin in psychiatric disease and importance of neuroimmunoendocrine interactions.

Authors:  F Waldhauser; B Ehrhart; E Förster
Journal:  Experientia       Date:  1993-08-15

Review 8.  Melatonin's neuroprotective role in mitochondria and its potential as a biomarker in aging, cognition and psychiatric disorders.

Authors:  Lindsay M Melhuish Beaupre; Gregory M Brown; Vanessa F Gonçalves; James L Kennedy
Journal:  Transl Psychiatry       Date:  2021-06-02       Impact factor: 6.222

9.  Are cardiometabolic and endocrine abnormalities linked to sleep difficulties in schizophrenia? A hypothesis driven review.

Authors:  Rébecca Robillard; Naomi L Rogers; Bradley G Whitwell; Tim Lambert
Journal:  Clin Psychopharmacol Neurosci       Date:  2012-04-30       Impact factor: 2.582

10.  Individual variations in serum melatonin levels through time: implications for epidemiologic studies.

Authors:  Leticia M Nogueira; Joshua N Sampson; Lisa W Chu; Kai Yu; Gerald Andriole; Timothy Church; Frank Z Stanczyk; Jill Koshiol; Ann W Hsing
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.